Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Smartox Biotechnology
Saint-Martin-d'Hères / Saint-Egrève, Auvergne-Rhône-Alpes, Francesmartox-biotech.com ↗
- Ownership
- Private
- Employees
- ~13
- Development stage
- Commercial
01
Overview
Smartox Biotechnology has developed a unique discovery platform for identifying therapeutic peptides from animal venoms and has patented its first compound in the field of Dravet syndrome. The company is preclinical-stage with no clinical results yet reported.
- Therapeutic areas
- Neurology
- Modalities
- PeptidesPeptide toxinsRecombinant protein (peptide synthesis services)
- Industry
- Biotech
Beyond the preview
Go deeper on Smartox Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Smartox Biotechnology.